Lexeo Therapeutics, Inc. (LXEO) Operating cash flow 2022–2025
Lexeo Therapeutics, Inc. (LXEO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$98.6MFY2025 · since FY2022: -$54.6M → -$98.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$98.6M | -21.5% |
| FY2024 | -$81.2M | -36.4% |
| FY2023 | -$59.5M | -9.0% |
| FY2022 | -$54.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LXEO financial trends
LXEO RevenueLXEO Net incomeLXEO Net marginLXEO Gross profitLXEO Gross marginLXEO Operating incomeLXEO Operating marginLXEO Free cash flowLXEO Capital expendituresLXEO Return on equityLXEO Stock buybacksLXEO Dividends paidLXEO Total assetsLXEO Total liabilitiesLXEO Shareholders’ equityLXEO overview →